Neutec Ar-Ge San ve Tic A.Ş

4 marketed · 4 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Neutec Ar-Ge San ve Tic A.Ş

What are Neutec Ar-Ge San ve Tic A.Ş's marketed drugs?

Top marketed products include Acetylcysteine/Doxofylline, Lansoprazole/Domperidone, Salmeterol/Fluticasone Capsair®, Tiotropium/Formoterol.

What is Neutec Ar-Ge San ve Tic A.Ş's pipeline?

Neutec Ar-Ge San ve Tic A.Ş has 4 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Infex 200 IR, Infex 400 MR, Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination.

Related